{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:01:41Z","timestamp":1781010101122,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15006-026-5951-6","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:06:36Z","timestamp":1781006796000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Versorgungsforschung bei niedergelassenen Pneumologinnen und Pneumologen","Health services research among registered pulmonologists: experiences and assessments of COPD therapy in German practice (DELFIN COPD 2)"],"prefix":"10.1007","volume":"168","author":[{"given":"Jutta","family":"Beier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Patzelt-Bath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"5951_CR2969","unstructured":"WHO. The top 10 causes of death. August 2024.  (abgerufen am 23.01.2025)"},{"key":"5951_CR2973","doi-asserted-by":"crossref","unstructured":"Buhl R et al. Real-world treatment of patients newly diagnosed with chronic obstructive pulmonary disease: a retrospective German claims data analysis. Int J Chron Obstruct Pulmon Dis. 2022;17:2355\u201367","DOI":"10.2147\/COPD.S375190"},{"key":"5951_CR2977","doi-asserted-by":"crossref","unstructured":"Laudahn B, Schmidtmann S. Wie praxisrelevant sind die GOLD-Empfehlungen f\u00fcr den ambulanten Alltag bei COPD? Pneumo News. 2015;7(5):53\u20137","DOI":"10.1007\/s15033-015-0233-5"},{"key":"5951_CR2981","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report. 2025. https:\/\/goldcopd.org\/2025-gold-report\/ (abgerufen am 28.02.2025)"},{"key":"5951_CR2985","doi-asserted-by":"crossref","unstructured":"Worth H et al. The 'real-life' COPD patient in Germany: The DACCORD study. Respir Med. 2016;111:64\u201371","DOI":"10.1016\/j.rmed.2015.12.010"},{"key":"5951_CR2989","doi-asserted-by":"crossref","unstructured":"Wang Z et al. Effects of smoking cessation on individuals with COPD: a systematic review and meta-analysis. Front Public Health. 2024;12:1433269","DOI":"10.3389\/fpubh.2024.1433269"},{"key":"5951_CR2993","doi-asserted-by":"crossref","unstructured":"Au DH et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med. 2009;24(4):457\u201363","DOI":"10.1007\/s11606-009-0907-y"},{"key":"5951_CR2997","doi-asserted-by":"crossref","unstructured":"Willemse BW et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464\u201376","DOI":"10.1183\/09031936.04.00012704"},{"key":"5951_CR3001","doi-asserted-by":"crossref","unstructured":"van Eerd EAM et al. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016; 2016(8):Cd010744","DOI":"10.1002\/14651858.CD010744.pub2"},{"key":"5951_CR3005","doi-asserted-by":"crossref","unstructured":"Pashutina Y et al. Attempts to quit smoking, use of smoking cessation methods, and associated characteristics among COPD patients. NPJ Prim Care Respir Med. 2022;32(1):50","DOI":"10.1038\/s41533-022-00316-5"},{"key":"5951_CR3011","doi-asserted-by":"crossref","unstructured":"Haluza D et al. Perceptions of practitioners on telehealth and app use for smoking cessation and COPD care \u2013 an exploratory study. Medicina (Kaunas). 2020;56(12):698","DOI":"10.3390\/medicina56120698"},{"key":"5951_CR3019","doi-asserted-by":"crossref","unstructured":"Agusti A et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev. 2011;20(121):183\u201394","DOI":"10.1183\/09059180.00004311"},{"key":"5951_CR3023","doi-asserted-by":"crossref","unstructured":"Kessler R et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264\u201372","DOI":"10.1183\/09031936.00051110"},{"key":"5951_CR3027","doi-asserted-by":"crossref","unstructured":"Partridge MR et al. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;25(8):2043\u20138","DOI":"10.1185\/03007990903103006"},{"key":"5951_CR3031","doi-asserted-by":"crossref","unstructured":"Stephenson JJ et al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577\u201386","DOI":"10.2147\/COPD.S76157"},{"key":"5951_CR3035","doi-asserted-by":"crossref","unstructured":"Beier J et al. Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study. Int J Chron Obstruct Pulmon Dis. 2017;12:1731\u201340","DOI":"10.2147\/COPD.S121723"},{"key":"5951_CR3039","doi-asserted-by":"crossref","unstructured":"Herth FJF et al. Unmet needs of patients with COPD in Germany: a retrospective, cross-sectional study. ERJ Open Res. 2025;11(3):00976-2024","DOI":"10.1183\/23120541.00976-2024"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-026-5951-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:06:51Z","timestamp":1781006811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-026-5951-6"}},"subtitle":["Erfahrungen und Einsch\u00e4tzungen zur COPD-Therapie in der deutschen Praxis (DELFIN COPD 2)"],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5951"],"URL":"https:\/\/doi.org\/10.1007\/s15006-026-5951-6","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"9 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jutta Beier nahm an Advisory Boards teil und hielt Vortr\u00e4ge im Rahmen von Fortbildungsveranstaltungen f\u00fcr Berlin-Chemie. Andrea Patzelt-Bath war zum Zeitpunkt der Erstellung des Manuskripts Mitarbeiterin von Berlin-Chemie.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}